People · Operator
Named in public records as an officer, director or promoter · active 2014–2021 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Wugen, Inc. | — | Other Health Care | Series D+ | $245.2M | $870.8M | 2020 |
| Lumena Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $51.4M | $1.6B | 2014 |
John P McKearn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John P McKearn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Grey | 1 | 10 |
| Drew Dennison | 1 | 7 |
| Niall O'Donnell | 1 | 7 |
| Bosun Hau | 1 | 6 |
| Matthew Cooper | 1 | 5 |
| Peter Kiener | 1 | 4 |
| Kevin Li | 1 | 4 |
| Bali Muralidhar | 1 | 3 |
| Kumar Srinivasan | 1 | 2 |
| Howard E. Greene | 1 | 2 |
| Alana B. McNulty | 1 | 2 |
| Keith Vendola | 1 | 2 |
| David R. Savello | 1 | 2 |
| Peter P Kiener | 1 | 1 |
| Jan K Davidson | 1 | 1 |
| Matthew P Cooper | 1 | 1 |
| Kevin P Li | 1 | 1 |
| Drew P Dennison | 1 | 1 |
| Alejandro B. Dorenbaum | 1 | 1 |
| Susan E. Dube | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.